Upadacitinib showed continued facial and body repigmentation in NSV through week 76, with numerically higher responses when combined with NB-UVB.
|Articles|July 1, 2010
Birthmarks in newborns can signal later problems
Vascular birthmarks are very common in newborns, and some varieties affect up to 50% of babies.
Advertisement
Vascular birthmarks are very common in newborns, and some varieties affect up to 50% of babies. The challenge for dermatologists can be the early diagnosis and the ability to distinguish the subtle differences between a banal birthmark and one that calls for quick action.
Advertisement
Related to this article
Can you guess the diagnosis?
The approval is based on BRAVE-AA-PEDS, in which 42% of adolescents receiving baricitinib 4 mg achieved at least 80% scalp hair coverage at week 36 vs 5% with placebo.
The FDA accepted the dersimelagon NDA with priority review for EPP and XLP; a decision on the oral MC1R agonist is expected by February 2027.
Children with atopic dermatitis have higher ADHD risk, particularly with early, severe disease and sleep disturbance, a review found.
Baseline severity and clinical phenotype may help predict response to systemic therapy in children with alopecia areata.
Can you guess the diagnosis?
Can you guess the diagnosis?
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
What the Camzyos approval means for patients with obstructive HCM
2
BLA submitted to FDA for Viaskin peanut patch in children aged 4 to 7 years with peanut allergy
3
FDA approves Camzyos for pediatric patients with symptomatic obstructive hypertrophic cardiomyopathy
4
First-in-human trial tests microneedle stamp approach for peanut allergy
5